192 related articles for article (PubMed ID: 20739208)
1. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients.
Gharibeh MY; Al Tawallbeh GM; Abboud MM; Radaideh A; Alhader AA; Khabour OF
Diabetes Metab; 2010 Dec; 36(6 Pt 1):443-9. PubMed ID: 20739208
[TBL] [Abstract][Full Text] [Related]
2. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
Zaidi SI; Shirwany TA
J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
[TBL] [Abstract][Full Text] [Related]
3. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
Al-Harithy RN; Al-Ghamdi S
Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin, resistin and insulin in obese diabetic women in Wad-Madani, Sudan.
Elamin MA; Youseif SM; Mohammed HA
Afr Health Sci; 2020 Mar; 20(1):266-276. PubMed ID: 33402915
[TBL] [Abstract][Full Text] [Related]
5. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.
Chanchay S; Tungtrongchitr R; Harnroongroj T; Phonrat B; Rungseesakorn O; Paksanont S; Pooudong S; Saowakontha S; Varongchayakul C
Int J Vitam Nutr Res; 2006 May; 76(3):125-31. PubMed ID: 17048191
[TBL] [Abstract][Full Text] [Related]
6. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
Lau CH; Muniandy S
Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
[TBL] [Abstract][Full Text] [Related]
7. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
Al-Sari IE; Al-Quobaili FA; Kabalan YM
Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
[TBL] [Abstract][Full Text] [Related]
8. Serum resistin positively correlates with serum lipids, but not with insulin resistance, in first-degree relatives of type-2 diabetes patients: an observational study in China.
Niu XH; Li L; Li JY; Song Q; Jin MM; Liu JX
Medicine (Baltimore); 2017 Apr; 96(16):e6622. PubMed ID: 28422857
[TBL] [Abstract][Full Text] [Related]
9. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
[TBL] [Abstract][Full Text] [Related]
10. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients.
Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; D'Angelo A; Cicero AF
J Pharm Pharm Sci; 2010; 13(3):378-90. PubMed ID: 21092710
[TBL] [Abstract][Full Text] [Related]
11. Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Li M; Fan R; Peng X; Huang J; Zou H; Yu X; Yang Y; Shi X; Ma D
Front Endocrinol (Lausanne); 2021; 12():695750. PubMed ID: 34603198
[TBL] [Abstract][Full Text] [Related]
12. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes.
Lu HL; Wang HW; Wen Y; Zhang MX; Lin HH
World J Gastroenterol; 2006 Mar; 12(11):1747-51. PubMed ID: 16586545
[TBL] [Abstract][Full Text] [Related]
13. Relationships between human serum resistin, inflammatory markers and insulin resistance.
Bo S; Gambino R; Pagani A; Guidi S; Gentile L; Cassader M; Pagano GF
Int J Obes (Lond); 2005 Nov; 29(11):1315-20. PubMed ID: 16044175
[TBL] [Abstract][Full Text] [Related]
14. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):592-9. PubMed ID: 18465683
[TBL] [Abstract][Full Text] [Related]
16. Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness.
Yazıcı D; Yavuz D; Öğünç AV; Sirikçi Ö; Toprak A; Deyneli O; Akalın S
Metab Syndr Relat Disord; 2012 Feb; 10(1):26-31. PubMed ID: 21933002
[TBL] [Abstract][Full Text] [Related]
17. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
Habib SS
Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
[TBL] [Abstract][Full Text] [Related]
18. [Serum resistin concentration and insulin resistance in obese children].
Liu GL; Fu XH; Jiang LH; Ma XC; Yang JY
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):114-7. PubMed ID: 16624027
[TBL] [Abstract][Full Text] [Related]
19. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
[TBL] [Abstract][Full Text] [Related]
20. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study.
Bouchard L; Weisnagel SJ; Engert JC; Hudson TJ; Bouchard C; Vohl MC; Pérusse L
J Endocrinol Invest; 2004 Dec; 27(11):1003-9. PubMed ID: 15754730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
